M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Aileron Therapeutics Inc to acquire Lung Therapeutics
Announced Oct 31, 2023 · Closed Oct 31, 2023 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Aileron Therapeutics Inc (ALRN)
- Target
- Lung Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Oct 31, 2023
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Ladenburg Thalmann
- To the target
- Clear Street
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations